Clinical trial
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in…
NCT00387946 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00387946 |
|---|---|
| Title | Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN) |
| Official title | An International, Seven-week, Double-blind, Placebo-controlled, Two Parallel Group Study to Assess the Efficacy of Dianicline 40 mg Bid as an Aid to Smoking Cessation in Cigarette Smokers |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation, Tobacco Use Cessation |
| Intervention type | Drug |
| Interventions | SSR591813L (dianicline) |
| Enrollment | 630 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Oct 13, 2006 |
| Last update posted | Feb 17, 2012 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: